Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
NCT03244072Phase 3Not yet recruiting
- Start
- Jun 2027
- Primary completion
- Oct 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Moxisurge in endophthalmitis. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
Moxisurge
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT03244072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03244072.